SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Caroline Cohen, Ghislaine Perrault, C. Voltz, +2

Behavioural Pharmacology

NeuropsychologyReceptor AntagonistDopamine-releasing EffectsSocial SciencesNicotine +18

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

Xavier Emonds‐Alt, Jean-Daniel Doutremepuich, Michel Héaulme, +11

European Journal of Pharmacology

Signal TransductionVivo Biological ActivitiesMedicineImmunologyReceptor (Biochemistry) +6

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Philippe Pichat, Olivier Bergis, Jean-Paul Terranova, +11

Neuropsychopharmacology

PsychiatryPsychotic DisorderMedicineExperimental Models PredictiveNicotine +8

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders

Guy Griebel, Jacques Simiand, R. Steinberg, +7

Journal of Pharmacology and Experimental Therapeutics

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne‐Bouhtou, +27

Neuropsychopharmacology

NeurophysiologyMedicineGlycine Transporter-1 Ssr504734Selective InhibitorPsychopharmacology +10

Biochemical and Pharmacological Activities of SR 142948A, a New Potent Neurotensin Receptor Antagonist

Danielle Gully, Bernard Labeeuw, Robert Boigegrain, +13

Journal of Pharmacology and Experimental Therapeutics

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

Bruno Biton, Olivier Bergis, Frédéric Galli, +29

Neuropsychopharmacology

Molecular PharmacologyFunctional ProfileMedicineNicotineReceptor (Biochemistry) +4

Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig

N. Marco, Anne-Marie Thirion, G Mons, +4

Neuropeptides

Cholinergic NeurotransmissionVivo Microdialysis ApproachHealth SciencesNeurophysiologyMedicine +10

Selective Blockade of Neurokinin-2 Receptors Produces Antidepressant-Like Effects Associated with Reduced Corticotropin-Releasing Factor Function

R. Steinberg, Richard Alonso, Guy Griebel, +8

Journal of Pharmacology and Experimental Therapeutics

Neuron-specific enolase as a marker of neuronal lesions during various comas in man☆

Hélène Scarna, B. Delafosse, R. Steinberg, +4

Neurochemistry International

Neuron-specific EnolaseVarious ComasNeurophysiologyNeuroanatomyMedicine +12